CD4 and myocardial infarction: In addition, Liu et al. reported that intramyocardial injection of human umbilical cord-derived mesenchymal stem cells promoted local CD4 + T-cell migration, angiogenesis, and suppressed hypertrophy following myocardial infarction [27].